Previous Article | Next Article ![]()
Infection and Immunity, April 2005, p. 1947-1953, Vol. 73, No. 4
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.4.1947-1953.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Oral Biology, New Jersey Dental School, Newark, New Jersey
Received 14 October 2004/ Returned for modification 16 November 2004/ Accepted 30 November 2004
|
|
|---|
|
|
|---|
A. actinomycetemcomitans forms extremely tenacious biofilms on inert surfaces in vitro (5), a property that may contribute to the ability of A. actinomycetemcomitans to colonize surfaces such as teeth and damaged heart tissue. Tight adherence is mediated by adhesive type IV pili which are composed of repeating subunits of a 6.5-kDa protein designated Flp-1 (10, 11). Mutants with mutations in the Flp-1 structural gene (flp-1) fail to form biofilms in vitro and are unable colonize the oral cavity, elicit an immune response, or cause bone loss in a rat model of periodontal disease (18). These findings suggest that biofilm formation plays an important role in the pathogenesis of A. actinomycetemcomitans. However, A. actinomycetemcomitans is routinely isolated from mucosal surfaces of predentate children as young as 20 days old (13, 20). In adults, A. actinomycetemcomitans is recovered more frequently and in higher numbers from oral mucosal surfaces than from subgingival and supragingival plaque, and mucosal surfaces can have high diagnostic value for identifying individuals colonized by A. actinomycetemcomitans (2, 15). These findings suggest that the oral mucosa is the initial site colonized by A. actinomycetemcomitans and the primary reservoir of A. actinomycetemcomitans in the oral cavity.
In vitro, A. actinomycetemcomitans is capable of binding to and invading epithelial cells (4, 14, 16), a property that may play a role in the ability of A. actinomycetemcomitans to colonize mucosal surfaces. Rose et al. (16) showed that A. actinomycetemcomitans cells express a 90-kDa surface-exposed protein, designated Aae, that is homologous to an epithelial cell adhesin (Hap) produced by H. influenzae (9). Aae is a member of the autotransporter family of bacterial proteins, which are characterized by a C-terminal domain that becomes integrated into the bacterial outer membrane and an N-terminal domain (the passenger domain) that is exposed on the cell surface (8). Rose et al. (16) showed that Aae mediates weak binding of A. actinomycetemcomitans to KB cells, a cell line that was originally thought to be derived from an epidermal carcinoma of the mouth but was subsequently found, based on isoenzyme, HeLa marker chromosome, and DNA fingerprinting analyses, to have been established via contamination by the human cervix carcinoma cell line HeLa (product information sheet ATCC CCL-17; American Type Culture Collection, Manassas, Va.).
In the present study we examined the host range specificity and tissue tropism of A. actinomycetemcomitans Aae. By using an A. actinomycetemcomitans aae knockout strain and a broad-host-range plasmid that expressed wild-type Aae in both A. actinomycetemcomitans and Escherichia coli, we obtained evidence that Aae mediates binding of A. actinomycetemcomitans to buccal epithelial cells (BECs) isolated specifically from humans and Old World primates.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
cells (Invitrogen). E. coli transformants were cultured in 15-ml polypropylene tubes containing 3 ml of Luria-Bertani broth supplemented with 50 µg of chloramphenicol per ml. Inoculated tubes were incubated at 37°C with shaking until the culture reached the mid-log phase. Isopropyl-ß-D-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM, and the culture was incubated for an additional 3 h. Cells were washed three times with PBS, the concentration was adjusted to ca. 107 CFU/ml, and then the cells were mixed with epithelial cells as described below.
Construction of an aae knockout strain.
Genomic DNA from A. actinomycetemcomitans strain CU1000 was amplified by PCR by using forward primer CGCGGATCCATAATGAAGAAAGTTTAGATGTGTTCTTTTTCAAA, which introduced a BamHI restriction site (underlined) 18 bp upstream of the aae initiation codon (boldface type), and reverse primer GGCGCTGCAGCTACCAGTAGTAATTCAGTTTTACTCC, which introduced a PstI restriction site (underlined) immediately downstream of the aae stop codon (boldface type). The PCR product (2.8 kb) was digested with BamHI and PstI and ligated into the BamHI/PstI sites of plasmid LITMUS28. The DNA sequence of the insert from the resulting plasmid (pVK45) was 99.4% identical (37 base changes) to the DNA sequence of aae from strain HK1651 (GenBank accession no. AY262734). Plasmid pVK45 was mutagenized with an EZ-TN transposon mutagenesis kit (Epicentre), which inserted a copy of the 2.0-kb kanamycin resistance transposon R6K
ori/KAN randomly into the plasmid. One plasmid (designated pVK52) contained a transposon insertion near the middle of aae at codon position 376. Plasmid pVK52 was used to transform A. actinomycetemcomitans strain IDH781N to kanamycin resistance by using a natural transformation protocol supplied by Mrinal Bhattacharjee and David Figurski (Columbia University). Genomic DNA isolated from the transformants was amplified by PCR by using the primers described above. One transformant (designated JK1046) which produced a PCR product that was 2.0 kb larger than that produced by strain IDH781N was selected. The insertion of transposon R6K
ori/KAN into the chromosomal aae locus of strain JK1046 was confirmed by DNA sequence analysis across the transposon junctions.
Genetic complementation of the aae mutation. The BamHI/PstI insert from pVK45 was ligated into the BamHI/PstI sites of the broad-host-range plasmid pJAK16, which placed aae under control of an IPTG-inducible tac promoter. The resulting plasmid (pVK43) was mobilized into A. actinomycetemcomitans strain IDH781N as described above. Transconjugants were grown in medium supplemented with 1 mM IPTG.
Construction of an flp-1 knockout strain.
A. actinomycetemcomitans strain IDH781N was transformed to kanamycin resistance with genomic DNA isolated from A. actinomycetemcomitans strain JK1009 by using the natural transformation protocol described above. Strain JK1009 contains an IS903
kan transposon insertion in the beginning of the flp-1 gene, which results in complete loss of pilus protein production and biofilm formation (11). Genomic DNA isolated from the transformants was amplified by PCR by using flp-1-specific primers which flanked the transposon insertion sites (12). One transformant (designated JK1047) that produced a PCR product of the expected size was selected. The transposon insertion site in the chromosome of strain JK1047 was confirmed by DNA sequence analysis. Genetic complementation of the flp-1 mutation in strain JK1047 was carried out by using plasmid pRA33, which contained wild-type flp-1 under control of an IPTG-inducible tac promoter.
Polystyrene adherence assay. A quantitative adherence assay was carried out in 96-well polystyrene microtiter plates as previously described (11). Briefly, cells were inoculated into the wells of the microtiter plates and allowed to adhere for 1 h. Loosely adherent cells were removed by washing, and adherent cells were stained with crystal violet for 10 min and then washed extensively. The crystal violet remaining in each well was then solubilized in ethanol, and the absorbance of the solution at 595 nm was measured. Adherence was proportional to optical density. Polystyrene adherence assays were performed three times with similar results.
Isolation of epithelial cells. Buccal epithelial cells were collected from healthy human volunteers and from various mammalian species by scraping the inside of a cheek with a sterile tongue depressor. Cells were collected in 5 ml of PBS, washed once, and resuspended in PBS. BECs were counted with a hemocytometer and diluted in PBS to obtain a concentration of 103 to 104 cells/ml.
Human gingival, palatal, and tongue epithelial cells were collected by using a similar method. Cell lines A-549 (ATCC CCL-185; American Type Culture Collection), NHBE (BioWhittaker, Walkersville, Md.), and KB (ATCC CCL-17) were used as sources of human alveolar, bronchial, and cervical epithelial cells, respectively.
Epithelial cell binding assay. Binding of A. actinomycetemcomitans and E. coli cells to epithelial cells was measured by using the assay described by Fine and Furgang (4). Briefly, 250 µl of epithelial cells was mixed with 250 µl of bacterial cells in a 2-ml polypropylene microcentrifuge tube, resulting in a ratio of 103 to 104 bacterial cells per epithelial cell. The tube was gently rotated for 90 min at 37°C. The epithelial cells were separated from unbound bacteria by centrifugation through a Ficoll gradient, and the bacteria bound to the epithelial cells were diluted and plated on agar for enumeration. Attachment of bacterial cells to epithelial cells was confirmed by direct microscopic visualization of rhodamine-labeled E. coli against a fluorescein-cytokeratin-labeled BEC background. All assays were performed in duplicate and on at least three separate occasions. The significance of differences in binding was determined by using an unpaired, two-tailed t test (P < 0.05).
Preparation of anti-Aae antiserum. The N-terminal portion of aae that encodes the surface-exposed passenger domain of the Aae adhesin (corresponding to bp 160 to 1,878 in GenBank accession no. AY487820) was amplified by PCR by using genomic DNA isolated from A. actinomycetemcomitans strain CU1000 as a target. The forward primer (TCAACCGGCACATATGTCAGAGTTTAATGCTCA) introduced an NdeI restriction site (underlined) upstream of aae codon 54, and the reverse primer (GCTCGGTACCTGGGTTATATATCGTTGGG) introduced a KpnI restriction site (underlined) downstream of aae codon 626. The PCR product (1,754 bp) was digested with NdeI and KpnI and ligated into the NdeI/KpnI sites of the T7 expression vector pET-29b (Novagen), resulting in plasmid pVK71. Recombinant Aae passenger domain protein was purified from cultures of E. coli strain BL21(DE3) carrying pVK71 by using an Ni affinity column (Pharmacia model 154-0990). Immunization and bleeding of specific-pathogen-free female New Zealand White rabbits were carried out by Pocono Rabbit Farm and Laboratory (Canadensis, Pa.). The specificity of the rabbit antiserum was confirmed by probing filters containing immobilized Aae passenger domain with both preimmune and postimmune sera.
Microscopic assays for functional analysis. Human BECs and E. coli cells were mixed and incubated as described above. BECs incubated in the absence of bacterial cells were used as controls in all experiments. After Ficoll gradient centrifugation, BECs were washed with PBS and heat fixed onto glass microscope slides.
For immunofluorescence microscopy, microscope slides were treated with anti-Aae antiserum (diluted 1:160) for 60 min at room temperature to label bacterial cells. The slides were then washed twice in PBS and once in distilled water and air dried. The slides were then treated with a 1:20 dilution of tetramethyl rhodamine isocyanate-conjugated goat anti-rabbit immunoglobulin G (Sigma catalog no. T6778) for 60 min, washed with water, and air dried. To label BECs, slides were treated with a 1:50 dilution of fluorescein isothiocyanate-conjugated anti-cytokeratin monoclonal antibody (Sigma catalog no. F3418) for 60 min, washed with water, and air dried. The slides were viewed at a magnification of x400 by using an Olympus BX50WI fluorescence microscope equipped with fluorescein and rhodamine filters. Individual tetramethyl rhodamine isocyanate and fluorescein isothiocyanate images of each field were digitized and combined in Adobe Photoshop 4.0 to obtain a single dual-fluorescence image.
For crystal violet staining, microscope slides were treated with Gram crystal violet solution (Fisher catalog no. 23-291472) for 60 s and then rinsed extensively with distilled water and air dried. The slides were viewed at a magnification of x400 by using an Olympus BX50WI microscope under bright-field conditions. Images of each field were recorded and digitized with a computer.
Nucleotide sequence accession number. The DNA sequence of aae from A. actinomycetemcomitans strain CU1000 has been deposited in the GenBank database under accession no. AY487820.
|
|
|---|
![]() View larger version (21K): [in a new window] |
FIG. 1. Binding characteristics of wild-type A. actinomycetemcomitans strain IDH781 and isogenic aae mutant strain JK1046. (A) BEC binding assay. The bars indicate the mean numbers of A. actinomycetemcomitans (Aa) cells per BEC for duplicate samples, and the error bars indicate ranges. Plasmid pJAK16 was the vector, and plasmid pVK43 was pJAK16 containing aae. (B) Biofilm formation in the wells of a 96-well microtiter plate. The optical density at 590 nm [OD (590 nm)] was proportional to biofilm formation. Strain JK1047 is an isogenic flp-1 mutant of strain IDH781N that lacks adhesive pili. Plasmid pRA33 is pJAK16 containing flp-1. (C) Binding to BECs isolated from humans and various mammalian species. Solid bars, wild-type strain IDH781; open bars, aae mutant strain JK1046. The asterisks indicate Old World primates. The bars indicate the mean numbers of A. actinomycetemcomitans (Aa) cells per BEC for duplicate samples, and the error bars indicate ranges. The values for species lacking bars were <1 bacterial cell per 1,000 BECs.
|
Expression of aae in E. coli.
Plasmid pVK43 was transformed into E. coli strain DH5
. Transformants expressed Aae protein on the surface, as determined by immunofluorescence microscopy with anti-Aae antiserum and a rhodamine-labeled anti-rabbit immunoglobulin G secondary antibody (Fig. 2A and B). Microscopic examination of both rhodamine-labeled E. coli against a fluorescein-cytokeratin-labeled BEC background (Fig. 2C and D) and crystal violet-stained bacterial cells (Fig. 2E and F) confirmed that E. coli cells expressing Aae bound to human BECs.
![]() View larger version (67K): [in a new window] |
FIG. 2. Functional expression of A. actinomycetemcomitans aae in E. coli. (A, C, and E) E. coli strain DH5 carrying plasmid vector pJAK16; (B, D, and F) strain DH5 carrying plasmid pVK43 (pJAK16 plus aae). (A and B) Detection of Aae on the surface of E. coli by using anti-Aae rabbit antiserum and a rhodamine-labeled secondary antibody. (C and D) Binding of E. coli to human BECs visualized by using rhodamine-labeled A. actinomycetemcomitans against a fluorescein-cytokeratin-labeled BEC background. (E and F) Binding of E. coli to human BECs visualized by staining with crystal violet.
|
![]() View larger version (31K): [in a new window] |
FIG. 3. Equilibrium binding of bacterial cells to human BECs. The data are means for duplicate samples, whose values varied by <5%.
|
![]() View larger version (21K): [in a new window] |
FIG. 4. Binding of E. coli strain DH5 carrying plasmid pVK43 to epithelial cells isolated from humans and various mammalian species. The asterisks indicate Old World primates. The bars indicate mean numbers of E. coli cells per epithelial cell for duplicate samples, and the error bars indicate ranges. The values for species lacking bars were <1 bacterial cell per 1,000 BECs.
|
|
|
|---|
Although attachment is a prerequisite for oral infection by a microorganism, prospective infectious agents also face the challenge of the early host response. Polymorphonuclear leukocytes (PMNs) usually provide the most effective antibacterial defense in the initial stages of infection. In the case of A. actinomycetemcomitans, leukotoxin production may provide a bacterial strategy to counteract the PMN response. A. actinomycetemcomitans leukotoxin, which kills PMNs and macrophages isolated from humans and Old World primates, binds to LFA-1, a ß2 integrin protein that is not present on the surface of BECs. These data suggest that the narrow host ranges exhibited by Aae and leukotoxin evolved independently and that the evolution of host range specificity may be a complex process that involves several host-specific factors. These findings also suggest that the natural history of A. actinomycetemcomitans may date back at least 35 million years to the time when humans and Old World primates last had a common ancestor (22).
Our findings provide a molecular basis for the susceptibility of humans to colonization by A. actinomycetemcomitans. A complete understanding of the Aae-receptor interaction on a molecular level could be used to develop novel antiadhesive interventions that could have broad therapeutic and preventive applications for diseases caused by A. actinomycetemcomitans.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»